Lovsin Barle E - Search Results

1

Disease area and mode of action as criteria to assign a default occupational exposure limit.

Glogovac M, Paulson C, Lambert A, Winkler GC, Lovsin Barle E. Glogovac M, et al. Among authors: lovsin barle e. Regul Toxicol Pharmacol. 2021 Jun;122:104891. doi: 10.1016/j.yrtph.2021.104891. Epub 2021 Feb 12. Regul Toxicol Pharmacol. 2021. PMID: 33587935

2

Classification of dermal sensitizers in pharmaceutical manufacturing.

Winkler GC, Perino C, Araya SH, Bechter R, Kuster M, Lovsin Barle E. Winkler GC, et al. Among authors: lovsin barle e. Regul Toxicol Pharmacol. 2015 Aug;72(3):501-5. doi: 10.1016/j.yrtph.2015.05.026. Epub 2015 May 29. Regul Toxicol Pharmacol. 2015. PMID: 26028366

3

Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry.

Lovsin Barle E, Winkler GC, Glowienke S, Elhajouji A, Nunic J, Martus HJ. Lovsin Barle E, et al. Toxicol Sci. 2016 May;151(1):2-9. doi: 10.1093/toxsci/kfw028. Toxicol Sci. 2016. PMID: 27207978 Free PMC article. Review.

4

Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2.

Gromek K, Hawkins W, Bernier T, Sehner C, Zeller E, Schwind M, Pfister T, Kohan M, Osadolor O, Glogovac M, Tuschl G, Dolan DG, Lovsin Barle E. Gromek K, et al. Among authors: lovsin barle e. Regul Toxicol Pharmacol. 2020 Aug;115:104692. doi: 10.1016/j.yrtph.2020.104692. Epub 2020 Jun 6. Regul Toxicol Pharmacol. 2020. PMID: 32522580

5

Determination and application of the permitted daily exposure (PDE) for topical ocular drugs in multipurpose manufacturing facilities.

Lovsin Barle E, Bizec JC, Glogovac M, Gromek K, Winkler GC. Lovsin Barle E, et al. Pharm Dev Technol. 2018 Mar;23(3):225-230. doi: 10.1080/10837450.2017.1312442. Epub 2017 Apr 12. Pharm Dev Technol. 2018. PMID: 28361586

6

Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.

Araya S, Lovsin-Barle E, Glowienke S. Araya S, et al. Among authors: lovsin barle e. Regul Toxicol Pharmacol. 2015 Nov;73(2):515-20. doi: 10.1016/j.yrtph.2015.10.001. Epub 2015 Oct 8. Regul Toxicol Pharmacol. 2015. PMID: 26454093

7

Applicability of surface sampling and calculation of surface limits for pharmaceutical drug substances for occupational health purposes.

Jandard C, Hemming H, Prause M, Sehner C, Schwind M, Abromovitz M, Lovsin Barle E. Jandard C, et al. Among authors: lovsin barle e. Regul Toxicol Pharmacol. 2018 Jun;95:434-441. doi: 10.1016/j.yrtph.2017.12.020. Epub 2017 Dec 27. Regul Toxicol Pharmacol. 2018. PMID: 29288720

8

Use of the permitted daily exposure (PDE) concept for contaminants of intravitreal (IVT) drugs in multipurpose manufacturing facilities.

Lovsin Barle E, Pfister T, Fux C, Röthlisberger D, Jere D, Mahler HC. Lovsin Barle E, et al. Regul Toxicol Pharmacol. 2019 Feb;101:29-34. doi: 10.1016/j.yrtph.2018.10.007. Epub 2018 Oct 24. Regul Toxicol Pharmacol. 2019. PMID: 30367903

9

Identifying nonhazardous substances in pharmaceutical manufacturing and setting default health-based exposure limits (HBELs).

Wiesner L, Araya S, Lovsin Barle E. Wiesner L, et al. Among authors: lovsin barle e. J Appl Toxicol. 2022 Sep;42(9):1443-1457. doi: 10.1002/jat.4323. Epub 2022 Apr 4. J Appl Toxicol. 2022. PMID: 35315528

10

Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE).

Wiesner L, Prause M, Lovsin Barle E. Wiesner L, et al. Among authors: lovsin barle e. Pharm Dev Technol. 2018 Mar;23(3):261-264. doi: 10.1080/10837450.2017.1334665. Epub 2017 Jun 7. Pharm Dev Technol. 2018. PMID: 28535123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters